Compositions comprising recombinant bacillus cells and an insecticide
AssigneesBayer CropScience AG, Spogen Biotech Inc.
InventorsDamian Curtis, Brian THOMPSON
Life of this patent
Estimating the term…
Abstract
The present invention relates to a composition comprising a) recombinant exosporium-producing Bacillus cells that express a fusion protein comprising: (i) at least one plant growth stimulating protein or peptide and (ii) a targeting sequence that localizes the fusion protein to the exosporium of the Bacillus cells; and b) at least one particular insecticide disclosed herein in a synergistically effective amount. Furthermore, the present invention relates to the use of this composition as well as a method for enhancing plant growth, promoting plant health, and/or reducing overall damage of plants and plant parts.
Claims24
A composition comprising:
- a) recombinant exosporium-producing Bacillus cells that express a fusion protein comprising:
- (i) at least one protein or peptide selected from the group consisting of a plant growth stimulating protein or peptide and a protein or peptide with insecticidal activity;
- and
- (ii) a targeting sequence, exosporium protein, or exosporium protein fragment;
- and
- b) at least one insecticide selected from the group consisting of abamectin, carbofuran, cyazypyr, cycloaprid, spinosad, sulfoxaflor, and tefluthrin,
- in a synergistically effective amount.
(canceled)
16-19. (canceled)
24-25. (canceled)
A method of treating a plant, a plant part, or the locus surrounding the plant to enhance plant growth and/or promote plant health comprising the step of simultaneously or sequentially applying:
- a) recombinant exosporium-producing Bacillus cells that express a fusion protein comprising:
- (i) at least one plant growth stimulating protein or peptide;
- and
- (ii) a targeting sequence, exosporium protein, or exosporium protein fragment;
- and
- b) at least one insecticide selected from the group consisting of abamectin, carbofuran, cyazypyr, cycloaprid, spinosad, sulfoxaflor, and tefluthrin,
- in a synergistically effective amount.
28-31. (canceled)
Dependencies are inferred from the claim text.